Literature DB >> 8174297

Free radial forearm flap reconstruction in surgery of the oral cavity and pharynx: surgical complications, impairment of speech and swallowing.

I K Bodin1, M G Lind, C Arnander.   

Abstract

The first 100 consecutive free radial forearm flaps used in reconstruction for oral and pharyngeal cancer were investigated. Seven re-operations took place due to circulatory impairment of the flap. Two flaps underwent partial, and four total necrosis, one of those patients died of massive haemorrhage. Post-operative infection was significantly correlated to increased time between the last radiotherapy session and surgery. All but eight patients had post-operative impairment of swallowing and all but five patients had impairment of speech articulation or hypernasality. Post-operative time spent in hospital was a range of 12-122 days (mean 37 days). The 2-year survival rate was 70% and the 5-year survival rate was 45%.

Entities:  

Mesh:

Year:  1994        PMID: 8174297     DOI: 10.1111/j.1365-2273.1994.tb01143.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  3 in total

1.  Pharyngo-esophageal reconstruction using pectoralis major cutaneous muscular flap after total laryngopharyngectomy.

Authors:  Tzvetan Marinov; Alexander Valkov
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-16       Impact factor: 2.503

2.  Evaluation of light-touch sensation in the buccal mucosa of leprosy patients.

Authors:  S N Marta; C Sgavioli; P P Saraiva; R S Carvalho; M G A Nogueira; F C Monti; M Virmond
Journal:  Clin Oral Investig       Date:  2014-01-14       Impact factor: 3.573

3.  Reconstructive management of the rare bilateral oral submucos fibrosis using nasolabial flap in comparison with free radial forearm flap--a randomised prospective trial.

Authors:  Muhammad Faisal; Madiha Rana; Anjum Shaheen; Riaz Warraich; Horst Kokemueller; André Michael Eckardt; Nils-Claudius Gellrich; Majeed Rana
Journal:  Orphanet J Rare Dis       Date:  2013-04-08       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.